multiple sclerosis drug betaseron (Berlex Laboratories Inc)
90
Structured Review
Berlex Laboratories Inc
multiple sclerosis drug betaseron
Multiple Sclerosis Drug Betaseron, supplied by Berlex Laboratories Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+sclerosis+drug+betaseron/multiple+sclerosis+drug+betaseron/10__3905_slash_jpe__2001__319993-45-12-2
Average 90 stars, based on 1 article reviews
Multiple Sclerosis Drug Betaseron, supplied by Berlex Laboratories Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+sclerosis+drug+betaseron/multiple+sclerosis+drug+betaseron/10__3905_slash_jpe__2001__319993-45-12-2
Average 90 stars, based on 1 article reviews
multiple sclerosis drug betaseron - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Orphan Drug Act Article Snippet: FALL 2001 I n 1983, Congress approved the Orphan Drug Act (ODA) to stimulate the development of drugs targeting “orphan diseases.” An orphan disease, as defined by the law, is one that affects fewer than 200,000 Americans.. Some orphan diseases are well known by the public, such as cystic fibrosis and Lou Gehrig’s disease, but most are more obscure, such as Cooley’s Anemia and Alagille Syndrome.1 An estimated 6,000 orphan diseases exist that altogether affect roughly one in ten Americans, about 25 million people.2 On average, there are just 4,000 patients per orphan disease, an extremely small patient population.. Some orphan diseases have only several dozen patients. |